| For: | Brivio S, Cadamuro M, Strazzabosco M, Fabris L. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World J Hepatol 2017; 9(9): 455-468 [PMID: 28396716 DOI: 10.4254/wjh.v9.i9.455] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v9/i9/455.htm |
| Number | Citing Articles |
| 1 |
Jihee Won, Youngkyu Cho, Dahyun Lee, Bo Young Jeon, Jung-Won Ju, Seok Chung, Jhang Ho Pak, Paul J. Brindley. Clonorchis sinensis excretory-secretory products increase malignant characteristics of cholangiocarcinoma cells in three-dimensional co-culture with biliary ductal plates. PLOS Pathogens 2019; 15(5) doi: 10.1371/journal.ppat.1007818
|
| 2 |
Chen Yu Jiao, Hui Zhang, Gu Wei Ji, Qing Xu, Ming Lu, Biao Zhang, Yue Yang, Xue Hao Wang, Xiang Cheng Li. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study. European Radiology 2022; 32(12) doi: 10.1007/s00330-022-08914-0
|
| 3 |
Silvia Affὸ, Laura Sererols-Viñas, Gemma Garcia-Vicién, Massimiliano Cadamuro, Sanjukta Chakraborty, Alphonse E. Sirica. Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma. The American Journal of Pathology 2025; 195(3) doi: 10.1016/j.ajpath.2024.07.009
|
| 4 |
Shaozhen Rui, Yuqi Liu, Yongqing Zhao, Xiaoliang Zhu, Shanhui Liao, Wence Zhou. Cancer-associated fibroblasts in cholangiocarcinoma: the central nexus of tumor-stroma crosstalk and therapeutic translation. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1725948
|
| 5 |
Jian Yan, Gang Xiao, Caini Yang, Qinqin Liu, Cui Lv, Xianhuan Yu, Ziyu Zhou, Shusheng Lin, Zhenhua Bai, Haoming Lin, Rui Zhang, Chao Liu. Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network. Aging and disease 2024; 15(1) doi: 10.14336/AD.2023.0420
|
| 6 |
Xuan Li, Yan Wang, Renchu Guan, Nan Sheng, Shuangquan Zhang. Multi-Omics Profiling Unveils the Complexity and Dynamics of Immune Infiltrates in Intrahepatic Cholangiocarcinoma. Biology 2024; 13(10) doi: 10.3390/biology13100816
|
| 7 |
. 2020; doi: 10.70675/0fdedffez92dfz4dc3zbe4ez9fdf1fa28a26
|
| 8 |
Shuichi Aoki, Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, Aya Matsui, Mohammad R Nikmaneshi, Shuji Kitahara, Tai Hato, Xianfeng Chen, Kazumichi Kawakubo, Hadi T Nia, Ivy Chen, Daniel H Schanne, Emilie Mamessier, Kohei Shigeta, Hiroto Kikuchi, Rakesh R Ramjiawan, Tyge CE Schmidt, Masaaki Iwasaki, Thomas Yau, Theodore S Hong, Alexander Quaas, Patrick S Plum, Simona Dima, Irinel Popescu, Nabeel Bardeesy, Lance L Munn, Mitesh J Borad, Slim Sassi, Rakesh K. Jain, Andrew X Zhu, Dan G Duda. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma. Gut 2022; 71(1) doi: 10.1136/gutjnl-2020-322493
|
| 9 |
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune Biology. Cells 2023; 12(6) doi: 10.3390/cells12060846
|
| 10 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; doi: 10.1007/978-981-99-0815-8_53
|
| 11 |
Michela Anna Polidoro, Erika Ferrari, Cristiana Soldani, Barbara Franceschini, Giuseppe Saladino, Arianna Rosina, Andrea Mainardi, Francesca D’Autilia, Nicola Pugliese, Guido Costa, Matteo Donadon, Guido Torzilli, Simona Marzorati, Marco Rasponi, Ana Lleo. Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine. JHEP Reports 2024; 6(1) doi: 10.1016/j.jhepr.2023.100910
|
| 12 |
Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, Stephanie MacMaster, Konstantinos Gournopanos, Daniel Y. H. Soong, Kamila I. Musialik, Panagiota Tsokkou, Minn‐E Ng, William A. Cambridge, David H. Wilson, Michael H. Kagey, Walter Newman, Jeffrey W. Pollard, Luke Boulter. DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01. Liver International 2023; 43(1) doi: 10.1111/liv.15383
|
| 13 |
Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Nicole Francis, Rowan Seils, Sara Villamaria, Heather Francis. Recent Advances in Understanding Cholangiocarcinoma. F1000Research 2017; 6 doi: 10.12688/f1000research.12118.1
|
| 14 |
Boyu Sun, Ziyu Xun, Nan Zhang, Kai Liu, Xiangqi Chen, Haitao Zhao. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03158-4
|
| 15 |
Patutong Chatchawal, Molin Wongwattanakul, Patcharaporn Tippayawat, Nichada Jearanaikoon, Amonrat Jumniansong, Thidarat Boonmars, Patcharee Jearanaikoon, Bayden R. Wood. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared Imaging. Analytical Chemistry 2020; 92(23) doi: 10.1021/acs.analchem.0c02656
|
| 16 |
Anja Moncsek, Joachim C. Mertens. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_24
|
| 17 |
Veronica Porreca, Cristina Barbagallo, Eleonora Corbella, Marco Peres, Michele Stella, Giuseppina Mignogna, Bruno Maras, Marco Ragusa, Carmine Mancone. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches. Cancers 2024; 16(16) doi: 10.3390/cancers16162889
|
| 18 |
Gervásio Evangelista Brito Filho, Thalles Fernando Rocha Ruiz, Lorena Gabriela de Souza, Luara Jesus Ferrato, Fernanda Cristina Alcantara dos Santos, Patricia Simone Leite Vilamaior, Ellen Cristina Rivas Leonel, Sebastião Roberto Taboga. Mammary Gland Reactive Stroma Characterization at Aging After Bisphenol A Exposure During Hormonal Susceptibility Windows. Cell Biology International 2025; 49(4) doi: 10.1002/cbin.12280
|
| 19 |
Shan-Shan Wang, Jia Yuan, Xinyu Thomas Tang, Xiujuan Yin, Ke Fang, Lin Veronica Chen, Zhenggang Ren, Bo O. Zhou. Periductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis. Journal of Experimental Medicine 2025; 222(4) doi: 10.1084/jem.20232123
|
| 20 |
Vasiliki Michalarea, Elizabeth C. Smyth. Oncogenomics. 2019; doi: 10.1016/B978-0-12-811785-9.00020-X
|
| 21 |
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome. Scandinavian Journal of Gastroenterology 2020; 55(6) doi: 10.1080/00365521.2020.1774923
|
| 22 |
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti, Roberto Troisi. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World Journal of Gastrointestinal Oncology 2021; 13(5): 332-350 doi: 10.4251/wjgo.v13.i5.332
|
| 23 |
Alessandra Caligiuri, Maurizio Parola, Fabio Marra, Stefania Cannito, Alessandra Gentilini. Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.23
|
| 24 |
Alessandra Caligiuri, Mirella Pastore, Giulia Lori, Chiara Raggi, Giovanni Di Maira, Fabio Marra, Alessandra Gentilini. Role of Chemokines in the Biology of Cholangiocarcinoma. Cancers 2020; 12(8) doi: 10.3390/cancers12082215
|
| 25 |
Mingzhen Bai, Ping Yue, Wenkang Fu, Ruyang Zhong, Chongfei Huang, Ningzu Jiang, Long Gao, Ningning Mi, Haidong Ma, Yawen Lu, Liang Tian, Jinyu Zhao, Ziang Zhang, Yong Zhang, Jinduo Zhang, Yanxian Ren, Haiying Yu, Jia Yao, Dewei Li, Yanyan Lin, Wenbo Meng. Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity. Acta Pharmaceutica Sinica B 2026; 16(5) doi: 10.1016/j.apsb.2026.02.023
|
| 26 |
Lishuai Yao, Changshuai Zhou, Libao Liu, Jinyuan He, Youbo Wang, An Wang. Cancer-associated fibroblasts promote growth and dissemination of esophageal squamous cell carcinoma cells by secreting WNT family member 5A. Molecular and Cellular Biochemistry 2025; 480(6) doi: 10.1007/s11010-025-05223-0
|
| 27 |
Rizwan Ali, Sarah Huwaizi, Alshaimaa Alhallaj, Arwa Al Subait, Tlili Barhoumi, Hajar Al Zahrani, Abdullah Al Anazi, Abdul Latif Khan, Mohamed Boudjelal. New Born Calf Serum Can Induce Spheroid Formation in Breast Cancer KAIMRC1 Cell Line. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.769030
|
| 28 |
Eleonora Milani, Mario Strazzabosco, Luca Fabris, Massimiliano Cadamuro. Intrahepatic Cholangiocarcinoma. 2019; doi: 10.1007/978-3-030-22258-1_12
|
| 29 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174154
|
| 30 |
Xiao Lu, Shoujia Xu, Zhe Deng, Min-Jun Wang, Fei Chen. Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies. Precision Clinical Medicine 2025; 8(3) doi: 10.1093/pcmedi/pbaf021
|
| 31 |
Sukanya Roy, Shannon Glaser, Sanjukta Chakraborty. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00293
|
| 32 |
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi. Topics in the Surgery of the Biliary Tree. 2018; doi: 10.5772/intechopen.75516
|
| 33 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9) doi: 10.1038/s41575-020-0310-z
|
| 34 |
Yuqi Feng, Letian Fang, Guangwen Cao. Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer. Hepatoma Research 2025; doi: 10.20517/2394-5079.2024.132
|
| 35 |
Eleonora Corbella, Claudia Fara, Francesca Covarelli, Veronica Porreca, Biagio Palmisano, Giuseppina Mignogna, Alessandro Corsi, Mara Riminucci, Bruno Maras, Carmine Mancone. THBS1 and THBS2 Enhance the In Vitro Proliferation, Adhesion, Migration and Invasion of Intrahepatic Cholangiocarcinoma Cells. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031782
|
| 36 |
Javier Vaquero, Cindy Lobe, Sylvana Tahraoui, Audrey Clapéron, Martine Mergey, Fatiha Merabtene, Dominique Wendum, Cédric Coulouarn, Chantal Housset, Christèle Desbois-Mouthon, Françoise Praz, Laura Fouassier. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma. Clinical Cancer Research 2018; 24(17) doi: 10.1158/1078-0432.CCR-17-3725
|
| 37 |
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, Shahid A. Khan, Alex Loukas, Alphonse E. Sirica, Bin Tean Teh, Sopit Wongkham, Gregory J. Gores. Cholangiocarcinoma. Nature Reviews Disease Primers 2021; 7(1) doi: 10.1038/s41572-021-00300-2
|
| 38 |
Byung-Kwan Jeong, You Na Sung, Sung Joo Kim, Soyeon An, Hosub Park, Hee Sang Hwang, Hyo Jeong Kang, Jae Hoon Lee, Ki Byung Song, Kyu-pyo Kim, Dae Wook Hwang, Sang Soo Lee, Song Cheol Kim, Seung-Mo Hong. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas. Human Pathology 2019; 84 doi: 10.1016/j.humpath.2018.09.006
|
| 39 |
Hua-Xin Duan, Bo-Wen Li, Xin Zhuang, Lu-Ting Wang, Qian Cao, Ling-Hua Tan, Gui-Fang Qu, Shuang Xiao. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(6) doi: 10.1152/ajpgi.00264.2018
|
| 40 |
Eleanna Kaffe, Christiana Magkrioti, Vassilis Aidinis. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. Cancers 2019; 11(11) doi: 10.3390/cancers11111626
|
| 41 |
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.005
|
| 42 |
Margherita Correnti, Eleonora Binatti, Elena Gammella, Pietro Invernizzi, Stefania Recalcati. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells. Cancers 2022; 15(1) doi: 10.3390/cancers15010005
|
| 43 |
Luca Fabris, Massimiliano Cadamuro, Silvia Cagnin, Mario Strazzabosco, Gregory J. Gores. Liver Matrix in Benign and Malignant Biliary Tract Disease. Seminars in Liver Disease 2020; 40(03) doi: 10.1055/s-0040-1705109
|
| 44 |
Adriana Romanzi, Erica Villa. Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.53
|
| 45 |
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156 doi: 10.1016/bs.acr.2022.02.001
|
| 46 |
Yingjiao Zhu, Zhibin Qiao, Zhuhong Chen, Yahua Wu, Lirong Xiao, Fangyu Lin, Xiaoyan Lin, Xinli Wang. Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma. Cancer Biology & Therapy 2026; 27(1) doi: 10.1080/15384047.2026.2725344
|
| 47 |
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156 doi: 10.1016/bs.acr.2022.01.009
|
| 48 |
Longhao Zhang, Kai Zhang, Zhihong Chen, Xin Lu. Therapy-imprinted fibroblast memory in cholangiocarcinoma: rewiring CAF niches for immune evasion and treatment-resistant relapse. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1907838
|
| 49 |
Michela Anna Polidoro, Joanna Mikulak, Valentina Cazzetta, Ana Lleo, Domenico Mavilio, Guido Torzilli, Matteo Donadon. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World Journal of Gastroenterology 2020; 26(33): 4900-4918 doi: 10.3748/wjg.v26.i33.4900
|
| 50 |
Michele Montori, Chiara Scorzoni, Maria Eva Argenziano, Daniele Balducci, Federico De Blasio, Francesco Martini, Tiziana Buono, Antonio Benedetti, Marco Marzioni, Luca Maroni. Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy. Journal of Clinical Medicine 2022; 11(21) doi: 10.3390/jcm11216498
|
| 51 |
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156 doi: 10.1016/bs.acr.2022.01.010
|
| 52 |
Javier Vaquero, Lynda Aoudjehane, Laura Fouassier. Cancer-associated fibroblasts in cholangiocarcinoma. Current Opinion in Gastroenterology 2020; 36(2) doi: 10.1097/MOG.0000000000000609
|
| 53 |
Mirca Marini, Alessia Tani, Mirko Manetti, Eleonora Sgambati. Characterization and distribution of sialic acids in human testicular seminoma. Acta Histochemica 2020; 122(3) doi: 10.1016/j.acthis.2020.151532
|
| 54 |
Meaghan Torvund, Jayati Chakrabarti, Yana Zavros. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; doi: 10.1007/978-3-030-67951-4_6
|
| 55 |
Alessandra Gentilini, Mirella Pastore, Fabio Marra, Chiara Raggi. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. International Journal of Molecular Sciences 2018; 19(10) doi: 10.3390/ijms19102885
|
| 56 |
William P. Harris, Kit Man Wong, Supriya Saha, Imane El Dika, Ghassan K. Abou-Alfa. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Seminars in Oncology 2018; 45(3) doi: 10.1053/j.seminoncol.2018.03.002
|
| 57 |
Luis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, Benjamin S Dale, Nathania M Figueroa Guilliani, Nicholas A Ullman, Paul R Burchard, Shuyang S Qin, Peter G Juviler, Jessica Millian Keilson, Ashley B Morrison, Mary Georger, Rachel Jewell, Laura M Calvi, Timothy M Nywening, Michael R O'Dell, Aram F Hezel, Luis De Las Casas, Gregory B Lesinski, Jen Jen Yeh, Roberto Hernandez-Alejandro, Brian A Belt, David C Linehan. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. Gut 2022; 71(7) doi: 10.1136/gutjnl-2021-324109
|
| 58 |
Menghua Zhou, Chaoqun Wang, Shounan Lu, Yanan Xu, Zihao Li, Hongchi Jiang, Yong Ma. Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. EBioMedicine 2021; 67 doi: 10.1016/j.ebiom.2021.103375
|
| 59 |
Sergi Marco, Chiara Braconi. Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”. Clinical and Molecular Hepatology 2025; 31(1) doi: 10.3350/cmh.2024.0932
|
| 60 |
Luca Fabris, María J. Perugorria, Joachim Mertens, Niklas K. Björkström, Thorsten Cramer, Ana Lleo, Antonio Solinas, Hanna Sänger, Veronika Lukacs‐Kornek, Anja Moncsek, Alexander Siebenhüner, Mario Strazzabosco. The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14098
|
| 61 |
Amanda N. Ruggieri, Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X. Chen, Brian M. Olson, Chrystal M. Paulos, Bassel F. El-Rayes, Shishir K. Maithel, Nilofer S. Azad, Gregory B. Lesinski. Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer. Clinical Cancer Research 2022; 28(19) doi: 10.1158/1078-0432.CCR-22-1123
|
| 62 |
. 2019; doi: 10.70675/48189727z97c1z43efzbecdz2649f70acac8
|
| 63 |
Ines Malenica, Matteo Donadon, Ana Lleo. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers 2020; 12(8) doi: 10.3390/cancers12082190
|
| 64 |
Inthuon Kulma, Luxsana Panrit, Tullayakorn Plengsuriyakarn, Wanna Chaijaroenkul, Siriprapa Warathumpitak, Kesara Na-Bangchang. A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-020-03199-6
|
| 65 |
Massimiliano Cadamuro, Simone Brivio, Tommaso Stecca, Eleanna Kaffe, Valeria Mariotti, Chiara Milani, Romina Fiorotto, Carlo Spirli, Mario Strazzabosco, Luca Fabris. Animal models of cholangiocarcinoma: What they teach us about the human disease. Clinics and Research in Hepatology and Gastroenterology 2018; 42(5) doi: 10.1016/j.clinre.2018.04.008
|
| 66 |
Guido Carpino, Vincenzo Cardinale, Alessandra Di Giamberardino, Diletta Overi, Samantha Donsante, Tania Colasanti, Gaia Amato, Gianluca Mennini, Matteo Franchitto, Fabrizio Conti, Massimo Rossi, Mara Riminucci, Eugenio Gaudio, Domenico Alvaro, Carmine Mancone. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. Journal of Hepatology 2021; 75(6) doi: 10.1016/j.jhep.2021.07.016
|
| 67 |
Laura Sererols-Viñas, Gemma Garcia-Vicién, Paloma Ruiz-Blázquez, Ting-Fang Lee, Youngmin A. Lee, Ester Gonzalez-Sanchez, Javier Vaquero, Anna Moles, Aveline Filliol, Silvia Affò. Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer. Seminars in Liver Disease 2025; 45(01) doi: 10.1055/a-2551-0724
|
| 68 |
Sumera I. Ilyas, Shahid A. Khan, Christopher L. Hallemeier, Robin K. Kelley, Gregory J. Gores. Cholangiocarcinoma — evolving concepts and therapeutic strategies. Nature Reviews Clinical Oncology 2018; 15(2) doi: 10.1038/nrclinonc.2017.157
|
| 69 |
Suyanee Thongchot, Alessandra Ferraresi, Chiara Vidoni, Amreen Salwa, Letizia Vallino, Yingpinyapat Kittirat, Watcharin Loilome, Nisana Namwat, Ciro Isidoro. Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. Cancer Letters 2024; 582 doi: 10.1016/j.canlet.2023.216589
|
| 70 |
Giovanni Brandi, Simona Tavolari. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_22
|
| 71 |
Sven H. Loosen, Tom F. Ulmer, Simon Labuhn, Jan Bednarsch, Sven A. Lang, Patrick H. Alizai, Anne T. Schneider, Mihael Vucur, Ulf P. Neumann, Tom Luedde, Christoph Roderburg. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer. Cancers 2022; 14(17) doi: 10.3390/cancers14174073
|
| 72 |
Chotirat Rattanasinchai, Panida Navasumrit, Mathuros Ruchirawat. Elevated ITGA2 expression promotes collagen type I-induced clonogenic growth of intrahepatic cholangiocarcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26747-1
|
| 73 |
Sumera I. Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J. Gores. Cholangiocarcinoma — novel biological insights and therapeutic strategies. Nature Reviews Clinical Oncology 2023; 20(7) doi: 10.1038/s41571-023-00770-1
|
| 74 |
Hong Kyu Lee, Yun-Jung Na, Su-Min Seong, Dohee Ahn, Kyung-Chul Choi. Cordycepin Enhanced Therapeutic Potential of Gemcitabine against Cholangiocarcinoma via Downregulating Cancer Stem-Like Properties. Biomolecules & Therapeutics 2024; 32(3) doi: 10.4062/biomolther.2023.198
|
| 75 |
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma. Scandinavian Journal of Gastroenterology 2020; 55(1) doi: 10.1080/00365521.2019.1708449
|
| 76 |
Massimiliano Cadamuro, Rocio I.R. Macias, Alastair J. Strain, Mario Strazzabosco, Paolo Simioni, Jose J.G. Marin, Luca Fabris. Unmet needs in basic and translational research in Cholangiocarcinoma. Liver Cancer International 2022; 3(1) doi: 10.1002/lci2.39
|
| 77 |
Xiaoxiang Rong, Jiayun Guan, Chanqi Ye, Qiong Li, Mingyu Wan, Wenguang Fu, Jinzhang Chen, Dayong Zheng, Ruyin Chen, Rui Zhou, Gautam Sethi, Yunlu Jia, Jian Ruan. SPINK1-driven cellular heterogeneity and interaction networks in intrahepatic cholangiocarcinoma revealed by integrated multi-omics analysis. Journal of Advanced Research 2026; 86 doi: 10.1016/j.jare.2025.11.011
|
| 78 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expression 2018; 18(1) doi: 10.3727/105221617X15088670121925
|
| 79 |
Juliette Paillet, Guido Kroemer, Jonathan G. Pol. Immune contexture of cholangiocarcinoma. Current Opinion in Gastroenterology 2020; 36(2) doi: 10.1097/MOG.0000000000000613
|
| 80 |
Elisa Lozano, Paula Sanchon-Sanchez, Ana Morente-Carrasco, Luis Miguel Chinchilla-Tábora, José L. Mauriz, Paula Fernández-Palanca, Jose J. G. Marin, Rocio I. R. Macias. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells 2023; 12(8) doi: 10.3390/cells12081141
|
| 81 |
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos, Flora Zagouri. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines 2021; 9(5) doi: 10.3390/vaccines9050422
|
| 82 |
Ting-Tsung Chang, Cheng-Hsun Ho, Matias A. Avila. Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma. PLOS ONE 2020; 15(8) doi: 10.1371/journal.pone.0238251
|
| 83 |
Paula Cantallops Vilà, Aashreya Ravichandra, Aloña Agirre Lizaso, Maria J. Perugorria, Silvia Affò. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology 2024; 79(4) doi: 10.1097/HEP.0000000000000206
|
| 84 |
Chunyu Zhao, Shanshuo Liu, Feng Gao, Yawen Zou, Zhigang Ren, Zujiang Yu. The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1008902
|
| 85 |
Shiraj Sen, Rachna T Shroff. Emerging Targeted and Immunotherapies in Cholangiocarcinoma. Oncology & Hematology Review (US) 2019; 15(2) doi: 10.17925/OHR.2019.15.2.71
|